With a market cap of $1.1 trillion, Eli Lilly and Company (LLY) is one of the world's largest pharmaceutical companies, focused on discovering, developing, manufacturing, and marketing innovative medicines for chronic diseases. The Indianapolis, Indiana-based company has become a leader in diabetes care, obesity treatments, immunology, oncology, and neuroscience.
Eli Lilly has been a standout performer over the past year, comfortably beating the broader market. LLY stock has increased 52.7% over this time frame, while the broader S&P 500 Index ($SPX) has gained 22.6%. The stock has cooled in 2026, rising 8.9% year to date compared to the S&P 500's 12.8% advance.